Alternatives to Bausch + Lomb
Bausch + Lomb is a MedTech tool: global eye health company offering contact lenses, lens care, supplements, and prescription pharmaceuticals. Here are the 53 closest alternatives, compared on pricing, features and what real users say.
The 20 closest MedTech companies to Bausch + Lomb
Tarsier PharmaNot ratedClinical-stage company developing novel treatments for ocular inflammatory blinding diseases.
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Fluxergy3.0 out of 5 (1)Develops a point-of-care diagnostic platform for rapid and accurate disease detection.
EyeGate PharmaceuticalsNot ratedClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
SchrödingerNot ratedPhysics-based software platform for molecular discovery and design in life and materials sciences.
CytoReasonNot ratedDevelops a computational model of the human body for drug discovery and development.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
Nucleai3.0 out of 5 (1)AI-powered spatial biology platform for precision medicine and drug development.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- ISISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUMNot rated
A consortium focused on incubating and developing technology in the medtech and pharma sectors in Israel.
ElicitNot ratedAI-powered research assistant for scientific literature review and data extraction.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
FIZE MedicalNot ratedFIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
QuantHealthNot ratedAI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Showing the next 20 closest matches. See the rest on the Bausch + Lomb profile.
Sponsored rows are paid and labelled. Advertise on this page
